Immune Response to Influenza Vaccine in Adults With B-cell Malignancies Treated With Idelalisib

NCT03701438 · clinicaltrials.gov ↗
TERMINATED
Status
2
Enrollment
INDUSTRY
Sponsor class

Stopped The Swissmedic agency released Gilead from this post marketing requirement.

Conditions

Interventions

Sponsor

Gilead Sciences